Archives: Biotech

Deep-dives and strategic analysis on the Biotech ecosystem in India.

BioAsia 2026: Why the 175-Exhibitor Record is a Bull Signal for Indian Life Sciences
17 February 2026

BioAsia 2026: Why the 175-Exhibitor Record is a Bull Signal for Indian Life Sciences
Pandorum’s $18M Series B: Why India is Finally Betting on the 'Hard' Sciences
9 February 2026

Pandorum’s $18M Series B: Why India is Finally Betting on the 'Hard' Sciences
The AI Replacement Cycle: Why Livspace’s 1,000-Staffer 'Strategic Reallocation' is a Wake-up Call for the Creative Economy
4 February 2026

The AI Replacement Cycle: Why Livspace’s 1,000-Staffer 'Strategic Reallocation' is a Wake-up Call for the Creative Economy